Soria JC - Search Results

1

Concurrent irradiation with the anti-programmed cell death ligand-1 immune checkpoint blocker durvalumab: Single centre subset analysis from a phase 1/2 trial.

Levy A, Massard C, Soria JC, Deutsch E. Levy A, et al. Among authors: soria jc. Eur J Cancer. 2016 Nov;68:156-162. doi: 10.1016/j.ejca.2016.09.013. Epub 2016 Oct 17. Eur J Cancer. 2016. PMID: 27764686 Clinical Trial.

2

Chemoprevention of lung cancer.

Soria JC, Kim ES, Fayette J, Lantuejoul S, Deutsch E, Hong WK. Soria JC, et al. Lancet Oncol. 2003 Nov;4(11):659-69. doi: 10.1016/s1470-2045(03)01244-0. Lancet Oncol. 2003. PMID: 14602246 Review.

3

Uncertain benefit from surgery in patients with lung metastases from breast carcinoma.

Planchard D, Soria JC, Michiels S, Grunenwald D, Validire P, Caliandro R, Girard P, Le Chevalier T. Planchard D, et al. Among authors: soria jc. Cancer. 2004 Jan 1;100(1):28-35. doi: 10.1002/cncr.11881. Cancer. 2004. PMID: 14692021 Free article.

4

Environmental, genetic, and molecular features of prostate cancer.

Deutsch E, Maggiorella L, Eschwege P, Bourhis J, Soria JC, Abdulkarim B. Deutsch E, et al. Among authors: soria jc. Lancet Oncol. 2004 May;5(5):303-13. doi: 10.1016/S1470-2045(04)01468-8. Lancet Oncol. 2004. PMID: 15120667 Review.

5

Use of angiogenesis inhibitors in tumour treatment.

Fayette J, Soria JC, Armand JP. Fayette J, et al. Among authors: soria jc. Eur J Cancer. 2005 May;41(8):1109-16. doi: 10.1016/j.ejca.2005.02.017. Eur J Cancer. 2005. PMID: 15911233 Review.

6

New concepts for phase I trials: evaluating new drugs combined with radiation therapy.

Deutsch E, Soria JC, Armand JP. Deutsch E, et al. Among authors: soria jc. Nat Clin Pract Oncol. 2005 Sep;2(9):456-65. doi: 10.1038/ncponc0295. Nat Clin Pract Oncol. 2005. PMID: 16264990 Review.

7

Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies.

Faivre S, Delbaldo C, Boige V, Pautier P, Soria JC, Namouni F, Peck R, Cohen M, Raymond E. Faivre S, et al. Among authors: soria jc. Eur J Cancer. 2008 Mar;44(5):674-82. doi: 10.1016/j.ejca.2008.01.016. Epub 2008 Mar 4. Eur J Cancer. 2008. PMID: 18308561 Clinical Trial.

8

Drug insight: gastrointestinal and hepatic adverse effects of molecular-targeted agents in cancer therapy.

Loriot Y, Perlemuter G, Malka D, Penault-Llorca F, Boige V, Deutsch E, Massard C, Armand JP, Soria JC. Loriot Y, et al. Among authors: soria jc. Nat Clin Pract Oncol. 2008 May;5(5):268-78. doi: 10.1038/ncponc1087. Epub 2008 Mar 18. Nat Clin Pract Oncol. 2008. PMID: 18349858 Review.

9

The efficacy and toxicity of EGFR in the settings of radiotherapy: Focus on published clinical trials.

Magné N, Chargari C, Castadot P, Ghalibafian M, Soria JC, Haie-Meder C, Bourhis J, Deutsch E. Magné N, et al. Among authors: soria jc. Eur J Cancer. 2008 Oct;44(15):2133-43. doi: 10.1016/j.ejca.2008.06.029. Epub 2008 Aug 7. Eur J Cancer. 2008. PMID: 18692389 Review.

10

MVP and vinorelbine for malignant pleural mesothelioma.

Mordant P, Loriot Y, Soria JC, Deutsch E. Mordant P, et al. Among authors: soria jc. Lancet. 2008 Aug 23;372(9639):629; author reply 629-30. doi: 10.1016/S0140-6736(08)61273-8. Lancet. 2008. PMID: 18722865 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters